HitGen Inc
688222
Company Profile
Business description
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.
Contact
No. 18, Section 2, Biocity Middle Road
Chengdu Tianfu International Biological City
Shuangliu District, Sichuan Province
Chengdu610093
CHNT: +86 2885197385
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
483
Stocks News & Analysis
stocks
Weekly Earnings Wrap: CBA, CSL, MQG and more
Everything you need to know on last weeks earnings results
stocks
ASX player rallies on small guidance upgrade
Our fair value is maintained despite investor enthusiasm.
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With strong fourth-quarter earnings and AI integration, here’s what we think of Alphabet stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,138.80 | 66.60 | -0.72% |
| CAC 40 | 8,340.56 | 27.32 | 0.33% |
| DAX 40 | 24,852.69 | 3.46 | -0.01% |
| Dow JONES (US) | 49,543.77 | 577.63 | -1.15% |
| FTSE 100 | 10,402.44 | 69.67 | -0.67% |
| HKSE | 26,505.79 | 526.75 | -1.95% |
| NASDAQ | 22,684.03 | 382.43 | -1.66% |
| Nikkei 225 | 57,031.15 | 608.69 | -1.06% |
| NZX 50 Index | 13,198.18 | 333.30 | -2.46% |
| S&P 500 | 6,857.31 | 84.16 | -1.21% |
| S&P/ASX 200 | 8,917.60 | 55.30 | -0.62% |
| SSE Composite Index | 4,096.86 | 37.16 | -0.90% |